US · JRI · ASSET MANAGEMENT - INCOME
Nuveen Real Asset Income and Growth Fund (JRI) intrinsic value and stock valuation
$10.53as of 2026-11-21 · Mkt cap 347.77M
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Nuveen Real Asset Income and Growth Fund DCF and intrinsic value
InvestorsCraft values JRI with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from JRI’s statements →
Nuveen Real Asset Income and Growth Fund Graham Number
Graham Number: $23.21d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2016–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Nuveen Multi-Asset Income Fund (NMAI) $11.91
- Virtus Convertible & Income Fund (NCV) $13.37
- PIMCO Income Strategy Fund (PFL) $6.56
- Cohen & Steers Closed-End Opportunity Fund, Inc. (FOF) $11.10
- Nuveen New York Quality Municipal Income Fund (NAN) $9.46
- Nuveen S&P 500 Dynamic Overwrite Fund (SPXX) $16.73
- Nuveen Global High Income Fund (JGH) $11.17
- PIMCO Strategic Income Fund (RCS) $4.85
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $43.6M | $41.7M | $14.6M | $16.5M | $76.9M |
| Operating income | $57.5M | $35.3M | $43.1M | -$-69.3M | $76.6M |
| Net income | $49.1M | $25.5M | $32.8M | -$-73.67M | $75M |
| EPSd | $1.79M | $930.3K | $1.2M | -$-2.68M | $2.73M |
| Operating cash flow | $19.6M | $14.2M | $21.8M | $54.5M | -$-2.39M |
| Capital expenditure | $0.00 | $0.00 | $0.00 | -$0.00 | $0.00 |
| Free cash flow | $19.6M | $14.2M | $21.8M | $54.5M | -$-2.39M |
| Total assets | $543.6M | $550M | $534.2M | $547.2M | $686.3M |
| Total debt | $174.1M | $183M | $153.7M | $167M | $197.9M |
| Net debt | $173.1M | -$-2.13M | $153.5M | $166.7M | $195.5M |
| Total equity | $367M | $361.5M | $375.3M | $372.5M | $477.9M |
| Cash and short-term investments | $10.2M | $14.6M | $240K | $320K | $2.41M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $43.6M | $41.7M | $14.6M | $16.5M | $76.9M |
| Cost of revenue | $5.62M | $5.84M | $9.24M | $6.37M | $6.52M |
| Gross profit | $38M | $35.9M | $34.4M | $10.2M | $70.4M |
| Research and development expenses | $0.00 | $0.00 | $0.00 | -$0.00 | $0.00 |
| Selling, general and administrative expenses | $0.00 | $1.1M | $590K | $880K | $660K |
| Other expenses | -$-19.53M | $960K | $1M | $1.16M | $1.31M |
| Operating expenses | -$-19.53M | $2.06M | $1.59M | $2.05M | $1.98M |
| Cost and expenses | -$-13.91M | $6.48M | -$-28.49M | $85.8M | $1.98M |
| Interest income | $31.3M | $12.7M | $11.6M | $9.82M | $8.56M |
| Interest expense | $8.6M | $9.24M | $9.24M | $4.36M | $1.58M |
| Depreciation and amortization | $0.00 | $0.00 | $0.00 | $230K | $240K |
| Ebitda | $57.7M | $35.3M | $43.1M | -$-69.08M | $76.8M |
| Operating income | $57.5M | $35.3M | $43.1M | -$-69.3M | $76.6M |
| Total other income/expenses, net | -$-8.4M | -$-9.75M | -$-10.28M | -$-4.36M | -$-1.58M |
| Income before tax | $49.1M | $25.5M | $32.8M | -$-73.67M | $75M |
| Income tax expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $49.1M | $25.5M | $32.8M | -$-73.67M | $75M |
| Weighted average shares outstanding | $27.4M | $27.4M | $27.3M | $27.5M | $27.5M |
| Weighted average diluted shares outstanding | $27.4M | $27.4M | $27.3M | $27.5M | $27.5M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $10.2M | $14.6M | $240K | $320K | $2.41M |
| Net receivables | $4.97M | $5.06M | $4.76M | $7.45M | $6.45M |
| Inventory | $0.00 | $0.00 | $0.00 | $29.5M | $29.8M |
| Total current assets | $15.1M | $14.6M | $5M | $7.77M | $8.87M |
| Property, plant and equipment, net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Goodwill and intangible assets | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Long-term investments | $528.5M | $542.8M | $509.2M | $539.4M | $676.5M |
| Total non-current assets | $528.5M | $542.8M | $529.2M | $539.4M | $676.5M |
| Total assets | $543.6M | $550M | $534.2M | $547.2M | $686.3M |
| Accounts payable | $1.7M | $3.57M | $980K | $1.8M | $3.7M |
| Short-term debt | $3.18M | $4.08M | $2.04M | $0.00 | $0.00 |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $3.18M | $5.24M | $3.03M | $1.8M | $3.7M |
| Long-term debt | $170.9M | $183M | $153.7M | $167M | $197.9M |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $173.4M | $184.9M | $157.9M | $173M | $197.9M |
| Capital lease obligations | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total liabilities | $176.6M | $188.5M | $158.9M | $174.8M | $208.4M |
| Common stock | $270K | $270K | $270K | $270K | $270K |
| Retained earnings | -$-166.41M | -$-193.85M | -$-200.99M | -$-216M | -$-121.74M |
| Accumulated other comprehensive income (loss) | $0.00 | $0.00 | -$-200.99M | -$-216M | -$-121.74M |
| Total equity | $367M | $361.5M | $375.3M | $372.5M | $477.9M |
| Total investments | $537.6M | $555.2M | $509.2M | $539.4M | $676.5M |
| Total debt | $174.1M | $183M | $153.7M | $167M | $197.9M |
| Net debt | $173.1M | -$-2.13M | $153.5M | $166.7M | $195.5M |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $49.1M | $25.5M | $32.8M | -$-73.67M | $75M |
| Depreciation and amortization | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Stock-based compensation | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in working capital | -$-1.68M | $2.27M | $1.71M | -$-3.35M | $830K |
| Accounts receivable | $90K | -$-300K | $2.69M | -$-990K | $1.01M |
| Inventory | $0.00 | $0.00 | $0.00 | $100K | $0.00 |
| Accounts payable | -$-1.68M | $2.51M | -$-1.75M | -$-2.02M | -$-530K |
| Net cash provided by operating activities | $19.6M | $14.2M | $21.8M | $54.5M | -$-2.39M |
| Investments in property, plant and equipment | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acquisitions, net | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net cash used for investing activities | $29.8M | -$-16.76M | $21.2M | $33.6M | -$-27.18M |
| Common stock issued | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock repurchased | $0.00 | $0.00 | -$-410K | $0.00 | $0.00 |
| Dividends paid | -$-43.61M | -$-39.33M | -$-29.52M | -$-31.79M | -$-31.79M |
| Net cash used for financing activities | -$-53.73M | -$-12.28M | -$-44.86M | -$-57.6M | $110K |
| Net change in cash | -$-1.09M | $1.88M | -$-80K | -$-3.06M | -$-2.28M |
| Cash at end of period | $1.03M | $2.13M | $240K | $320K | $3.38M |
| Operating cash flow | $19.6M | $14.2M | $21.8M | $54.5M | -$-2.39M |
| Capital expenditure | $0.00 | $0.00 | $0.00 | -$0.00 | $0.00 |
| Free cash flow | $19.6M | $14.2M | $21.8M | $54.5M | -$-2.39M |
Line items
Line items
Line items
About Nuveen Real Asset Income and Growth Fund
The Nuveen Real Asset Income and Growth Fund is a closed-ended, balanced mutual fund, initially launched by Nuveen Investments, Inc. Its management is a collaborative effort between Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. The fund strategically invests in global public equity markets, including depository receipts and a particular emphasis on companies within the real estate sector. For its fixed income allocation, the fund targets securities with an 'investment grade quality' profile, accepting ratings as low as BB+/Ba1 or even lower. This fund, domiciled in the United States, was established on April 25, 2012.
- CEO
- John G. Wenker
- Employees
- 0
- Beta
- 0.90
Explore
Frequently asked questions
What is the intrinsic value of Nuveen Real Asset Income and Growth Fund (JRI)?
Nuveen Real Asset Income and Growth Fund (JRI) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is JRI undervalued?
JRI trades at a price of $10.53 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.